tm logo

Monitor this mark

View On USPTO

MEZAVANT
Live/Pending
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER

record initialized not assigned to examiner

on 03 Jul 2024

Last Applicant/ Owned by

Nogra Pharma Limited

33, Sir John Rogerson's Quay

Dublin

IE

2

Serial Number

98631731 filed on 03rd Jul 2024

Registration Number

N/A

Correspondent Address

Jacqueline M. Stelling

Jacqueline M. Stelling JMS Legal LLC

Westfield, NJ 07090

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

MEZAVANT

Pharmaceutical preparation, namely aminosalicylic acid in capsule, granule, tablet, suppository or enema forms suitable for the treatment of gastrointestinal diseases

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparation, namely aminosalicylic acid in capsule, granule, tablet, suppository or enema forms suitable for the treatment of gastrointestinal diseases

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 98631731

Mark Type

No Service/Collective Mark

Attorney Docket Number

No TCO.TM.03

44D Filed

No

44D Current

No

44E filed

Yes

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Status DateAction Taken
03rd Jul 2024NEW APPLICATION ENTERED